Breast Cancer Estrogen and Progesterone Receptors: Associations with Patients' Clinical and Epidemiologic Characteristics

Autor: R. Plaino, C. Epifani, Antonio Nicolucci, F. Schittulli, T. Pedicini, G. Ambrosini, Roldano Fossati, F. Berardi, Alessandro Liberati, E. Locatelli, L. Busana, L. Armaroli, M. Indelli, M. Molteni, M. Majno, G. Gavazzini, F. Smerieri, A. Zamboni, S. Magnanini, R. Sisto, M. Biasio, D. Cosentino, Adriano Piffanelli, A. Santini, A. Rolfo, C. Poma, Silvia Marsoni, D. Palmieri, E. Aitini, A. Alexanian, O. Gottardi, G. Vaudano, G. Scognamiglio, G. Scoletta, P. Ghezzi, M. Giganti, F. Buda, G. Di Biagio, Fabio Parazzini, V. Saba, G. Marini, A. Pluchinotta, N. Monferroni, C. Confalonieri, B. Trolli, F. Testore, G. Gritti, N. Tavoni, L. Galletto, O. Nascimben, F. Peradotto, M. Monti, L. Isa, M. Rinaldini, D. Perroni, M. Braga, I. Lomonaco, P. Viola, E. Ghislandi, A. Richetti, M. R. Giolito, R. Scapaticci, M. Fumagalli

Publikováno v: Tumori Journal. 77:472-478

A total of 1095 patients with operable breast cancer and en-rolled in a randomized clinical trial were analysed for estrogen (ER) and progesterone (PgR) receptor content of their primary tumor, and the relationships between steroid receptor status an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5674fb4300d6ed86a146c6b92a11442
https://doi.org/10.1177/030089169107700605